PPARGC1A and chronic obstructive pulmonary disease: In addition, decreased expression of PPARGC1A has been observed in experimental models of CS-induced COPD, e.g., mice instilled with CS extract41 or in mice instilled with lipopolysaccharide and CS42, while elevated abundance of PPARGC1A have been observed in rats treated with CS+ lipopolysaccharide38.